Literature DB >> 21554423

Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.

M Karthaus1, M J G T Rüping, O A Cornely, A Steinbach, A H Groll, C Lass-Flörl, H Ostermann, M Ruhnke, J J Vehreschild.   

Abstract

The objectives of this study were to identify unsolved issues in the management of invasive candidiasis, identify controversies and achieve consensus. The German Speaking Mycological Society (Deutschsprachige Mykologische Gesellschaft, DMykG e.V.) asked other German infectious diseases (ID) and mycological societies to submit unsolved issues concerning the diagnosis and treatment of fungal infections. Based on these contributions, a digital web-based questionnaire of 12 questions on Candida infections was designed to be completed by experts of the participating societies. Controversial results were identified by a mathematical model and were discussed at a consensus conference during the 43rd Annual Meeting of the DMykG e.V. in Cologne, Germany. Forty-two individuals completed the questionnaire. Analysis showed a strong consensus on treatment indications, choice of antifungals for clinical situations, handling of central venous catheters, duration of treatment and role of susceptibility testing. Opinions diverged on: initial treatment of haemodynamically stable neutropenic and haemodynamically unstable non-neutropenic patients, step down to oral treatment and the differential role of the echinocandins. These questions were presented for discussion at the expert consensus conference. In three of four questions, consensus was achieved. A two-step approach - web-based survey plus classical panel discussion - allows to capture expeditiously the opinions of a large and diverse group of individuals, to identify controversial issues and to resolve them in a personal, interactive setting. Thus, expert consensus was achieved on nine of 12 important questions on how to treat invasive candidiasis.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554423     DOI: 10.1111/j.1439-0507.2010.01988.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  8 in total

Review 1.  Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

2.  Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.

Authors:  Brunella Posteraro; Alberto Ruggeri; Elena De Carolis; Riccardo Torelli; Antonietta Vella; Flavio De Maio; Walter Ricciardi; Patrizia Posteraro; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

3.  Outstanding personalities in German-speaking mycology : Dedicated to Professor Dr. Johannes Müller.

Authors:  Claus Seebacher; Torello Lotti; Maria Grazia Roccia; Massimo Fioranelli; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2017-02-23

4.  Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship.

Authors:  Sibylle C Mellinghoff; Pia Hartmann; Florian B Cornely; Laura Knauth; Felix Köhler; Philipp Köhler; Carolin Krause; Christine Kronenberg; Sarah-Leonie Kranz; Vidya Menon; Hannah Müller; Jan-Hendrik Naendrup; Stefan Pützfeld; Anna Ronge; Jule Rutz; Danila Seidel; Hilmar Wisplinghoff; Oliver A Cornely
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-13       Impact factor: 3.267

5.  Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis.

Authors:  Antonietta Vella; Elena De Carolis; Luisa Vaccaro; Patrizia Posteraro; David S Perlin; Markus Kostrzewa; Brunella Posteraro; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

6.  Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.

Authors:  Michael A Pfaller; Shawn A Messer; Leah N Woosley; Ronald N Jones; Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2013-05-29       Impact factor: 5.948

Review 7.  An Italian consensus for invasive candidiasis management (ITALIC).

Authors:  L Scudeller; C Viscoli; F Menichetti; V del Bono; F Cristini; C Tascini; M Bassetti; P Viale
Journal:  Infection       Date:  2013-11-25       Impact factor: 3.553

Review 8.  Antifungal susceptibility testing: current role from the clinical laboratory perspective.

Authors:  Brunella Posteraro; Riccardo Torelli; Elena De Carolis; Patrizia Posteraro; Maurizio Sanguinetti
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.